These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33078312)

  • 1. Omission of Surgical Axillary Lymph Node Staging in Patients with Tubular Breast Cancer.
    Özkurt E; Wong S; Rhei E; Golshan M; Brock J; Barbie TU
    Ann Surg Oncol; 2021 May; 28(5):2589-2598. PubMed ID: 33078312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
    Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
    Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
    Ramzi S; Najeeb E; Coulthard J; Jenkins S
    Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
    Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
    Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
    Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
    Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive and Non-invasive Ductal Carcinoma within Malignant Phyllodes Tumour with Axillary Lymph Node Metastases.
    Erdogan O; Parlakgumus A; Tas ZA; Yener K; Turan U
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):S92-S94. PubMed ID: 36210658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overuse of Axillary Surgery in Patients with Ductal Carcinoma In Situ: Opportunity for De-escalation.
    Piltin MA; Hoskin TL; Day CN; Habermann EB; Boughey JC
    Ann Surg Oncol; 2022 Nov; 29(12):7705-7712. PubMed ID: 35789303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of sentinel lymph node metastases in patients with favorable breast cancer histologic subtypes.
    Wong SL; Chao C; Edwards MJ; Carlson DJ; Laidley A; Noyes RD; McGlothin T; Ley PB; Tuttle T; Schadt M; Pennington R; Legenza M; Morgan J; McMasters KM;
    Am J Surg; 2002 Dec; 184(6):492-8; discussion 498. PubMed ID: 12488144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubular carcinoma of the breast: a population-based study of nodal metastases at presentation and of patterns of relapse.
    Kader HA; Jackson J; Mates D; Andersen S; Hayes M; Olivotto IA
    Breast J; 2001; 7(1):8-13. PubMed ID: 11348409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.
    Si J; Guo R; Huang N; Xiu B; Zhang Q; Chi W; Wu J
    Cancer Med; 2019 Dec; 8(18):7586-7593. PubMed ID: 31660702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery.
    Tadros AB; Yang WT; Krishnamurthy S; Rauch GM; Smith BD; Valero V; Black DM; Lucci A; Caudle AS; DeSnyder SM; Teshome M; Barcenas CH; Miggins M; Adrada BE; Moseley T; Hwang RF; Hunt KK; Kuerer HM
    JAMA Surg; 2017 Jul; 152(7):665-670. PubMed ID: 28423171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?
    Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M
    Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing harms from treatment. Sixteen years of surgery of the axilla for screen-detected breast cancers in Italy.
    Lazzaretti MG; Ponti A; Mano MP; Barca A; Casella D; Frigerio A; Giordano L; Mantellini P; Paduos A; Pitarella S; Ravaioli A; Taffurelli M; Tomatis M; Segnan N
    Breast; 2018 Dec; 42():15-22. PubMed ID: 30138762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular carcinoma and grade 1 (well-differentiated) invasive ductal carcinoma: comparison of flat epithelial atypia and other intra-epithelial lesions.
    Kunju LP; Ding Y; Kleer CG
    Pathol Int; 2008 Oct; 58(10):620-5. PubMed ID: 18801081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
    Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
    Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
    Han JS; Molberg KH; Sarode V
    Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.